Related Experiment Video
Updated: May 26, 2026

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
Published on: February 21, 2025
Second solid tumors: screening and management guidelines in long-term survivors after allogeneic stem cell
Gerard Socié1, J Douglas Rizzo
1Hematology Transplantation, APHP Hospital Saint Louis and University Paris VII Denis Diderot, Paris, France. gerard.socie@sls.aphp.fr
Abstract:
With greater numbers of patients surviving long-term after allogeneic stem cell transplantation (SCT), second malignancies have increasingly been recognized. Secondary solid tumors, the most prevalent second malignancies after allogeneic SCT, are reviewed with particular emphasis on recent developments in the pathogenesis, early diagnosis, and treatment of these transplant-related complications.
Related Concept Videos
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Cancer Survival Analysis
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Treatment Resistant Cancers
